Wall Street Experts

Prognozy kwartalne Sangamo Therapeutics, Inc.

2021-012022-012023-012024-012025-012026-012027-01050M100M150M
Prognozy przychodówPrzychody

Dane w mln

3 12 2 11 10 1 9 0
Okres 2024-12-31 2024-12-31 2025-03-31 2025-03-31 2025-06-30 2025-06-30 2025-09-30 2025-09-30 2025-12-31 2025-12-31 2026-03-31 2026-03-31 2026-06-30 2026-06-30 2026-09-30 2026-09-30 2026-12-31 2026-12-31
Przychód (średnia) 11.70 11.70 8.90 8.90 29.90 29.90 7.00 7.00 13.80 13.80 20.65 20.65 21.65 21.65 22.65 22.65 37.05 37.05
Przychód Δ kw/kw -68.42% 0.00% -23.93% -23.93% 235.96% 235.96% -76.59% -76.59% 97.14% 97.14% 49.64% 49.64% 4.84% 4.84% 4.62% 4.62% 63.58% 63.58%
Przychód (min) 7.36 7.36 0.12 0.12 0.40 0.40 0.09 0.09 0.18 0.18 0.28 0.28 0.29 0.29 0.30 0.30 0.50 0.50
Przychód (max) 14.72 14.72 29.77 29.77 100.00 100.00 23.41 23.41 46.15 46.15 69.06 69.06 72.41 72.41 75.75 75.75 123.91 123.91
EBITDA (średnia) -10.52 -10.52 -8.00 -8.00 -26.89 -26.89 -6.29 -6.29 -12.41 -12.41 -18.57 -18.57 -19.47 -19.47 -20.37 -20.37 -33.32 -33.32
EBIT (średnia) -10.82 -10.82 -8.23 -8.23 -27.64 -27.64 -6.47 -6.47 -12.76 -12.76 -19.09 -19.09 -20.01 -20.01 -20.94 -20.94 -34.25 -34.25
EBIT % -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44% -92.44%
Zysk netto (średni) -20.10 -20.10 -25.84 -25.84 -3.46 -3.46 -14.16 -14.16 -22.97 -22.97 -19.09 -19.09 -19.82 -19.82 -20.56 -20.56 -15.42 -15.42
Zysk netto % -171.79% -171.79% -290.28% -290.28% -11.58% -11.58% -202.29% -202.29% -166.46% -166.46% -92.45% -92.45% -91.57% -91.57% -90.77% -90.77% -41.62% -41.62%
EPS (średnia)
Liczba analityków (Przychody) 5 5 1 1 6 6 2 2 2 2 5 5 4 4 4 4 5 5
Liczba analityków (EPS) 6 6 1 1 3 3 1 1 1 1 1 1 1 1 1 1 1 1
symbol SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO SGMO